Strategy chief exits as IDEX Corp (NYSE: IEX) eliminates role

Filing Impact

(Moderate)

Filing Sentiment

(Neutral)

Form Type

8-K

Rhea-AI Filing Summary

IDEX Corporation has announced a leadership change in its strategy function. On February 4, 2026, the company notified Roopa Unnikrishnan, its Senior Vice President, Chief Strategy and Innovation Officer and a current named executive officer, that her position will be eliminated effective February 28, 2026.

IDEX expects to enter into a separation agreement with Ms. Unnikrishnan under the termination-without-cause terms set out in her existing letter agreement, as previously described in the company’s proxy statement filed in March 2025. The filing does not describe broader organizational changes beyond this role elimination.

8-K Event Classification

Item 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers

1 item

Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers Governance

Key personnel changes including departures, elections, or appointments of directors and executive officers.

Understanding 8-K Material Events →

02/09/2026 - 04:36 PM

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d)

of The Securities Exchange Act of 1934

Date of Report: February 4, 2026

(Date of earliest event reported)

IDEX CORPORATION

(Exact name of registrant as specified in its charter)


Delaware	1-10235	36-3555336
(State or other jurisdiction of incorporation)	(Commission File Number)	(IRS Employer Identification No.)

3100 Sanders Road, Suite 301

Northbrook, Illinois 60062

(Address of principal executive offices, including zip code)

(847) 498-7070

(Registrant’s telephone number, including area code)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

☐	Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐	Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐	Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐	Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:


Title of each class	Trading Symbol(s)	Name of each exchange on which registered
Common Stock, par value $.01 per share	IEX	New York Stock Exchange

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Item 5.02 – Departure of Directors or Principal Officers; Election of Directors; Appointment of Principal Officers; Compensatory Arrangements of Certain Officers.

On February 4, 2026, IDEX Corporation (the “Company”), notified Roopa Unnikrishnan, Senior Vice President, Chief Strategy and Innovation Officer, and a current named executive officer of the Company, of the elimination of her position effective February 28, 2026.

In connection with Ms. Unnikrishnan’s separation of employment, the Company expects to enter into a separation agreement with Ms. Unnikrishnan under the terms of Ms. Unnikrishnan’s letter agreement with the Company for a termination without cause, as described in the Company’s Proxy Statement filed with the United States Securities and Exchange Commission on March 26, 2025.

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.


		IDEX CORPORATION

By:		/s/ LISA M. ANDERSON
		Lisa M. Anderson
		Senior Vice President, General Counsel, Chief Administrative Officer and Secretary

February 9, 2026

Source: View Original Filing on SEC EDGAR

FAQ

What executive leadership change did IDEX (IEX) disclose in this 8-K?

IDEX disclosed that Roopa Unnikrishnan, Senior Vice President, Chief Strategy and Innovation Officer, will have her position eliminated effective February 28, 2026. She is a current named executive officer, so her departure reflects a notable change in the company’s senior leadership team.

When does Roopa Unnikrishnan’s role at IDEX (IEX) end?

Her role ends effective February 28, 2026. IDEX notified her of the elimination of her position on February 4, 2026, providing several weeks between notice and the effective separation date for transition and formalization of the separation agreement terms.

How will IDEX (IEX) handle severance for Roopa Unnikrishnan?

IDEX expects to enter a separation agreement with Roopa Unnikrishnan under the termination-without-cause terms in her existing letter agreement. Those terms are described in the company’s proxy statement filed on March 26, 2025, which governs compensation and benefits upon separation.

What reason did IDEX (IEX) give for Roopa Unnikrishnan’s departure?

The company stated that Ms. Unnikrishnan’s position is being eliminated, effective February 28, 2026. The filing characterizes the separation as a termination without cause under her letter agreement, without describing performance issues or broader restructuring initiatives in the provided text.

Which executive signed the IDEX (IEX) 8-K about the officer departure?

The 8-K was signed on behalf of IDEX by Lisa M. Anderson. She holds the roles of Senior Vice President, General Counsel, Chief Administrative Officer and Secretary, indicating the filing reflects an official corporate decision authorized at a high administrative level.

Filing Exhibits & Attachments

3 documents